Alyeska Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $73.5M | Buy |
|
|||||
|
2021
Q1 | $42M | Buy |
|
|||||
|
2020
Q4 | $15.5M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $27.4M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.45M | Sell |
|
|||||
|
2016
Q4 | $96.3M | Buy |
|
|||||
|
2016
Q3 | $56.6M | Sell |
|
|||||
|
2016
Q2 | $120M | Buy |
|
|||||
|
2016
Q1 | $41.8M | Sell |
|
|||||
|
2015
Q4 | $79.4M | Sell |
|
|||||
|
2015
Q3 | $68.8M | Buy |
|
|||||
|
2015
Q2 | $56.7M | Buy |
|
|||||
|
2015
Q1 | $32.1M | Buy |
|
|||||
|
2014
Q4 | $28.4M | Buy |
|
|||||
|
2014
Q3 | $20.3M | Sell |
|
|||||
|
2014
Q2 | $28.2M | Buy |
|
|||||
|
2014
Q1 | $14.7M | Buy |
|
|||||
|
2013
Q4 | $11.3M | Buy |
|